- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapy of Cancer by Targeting Regulatory T cells
Authors
Keywords
Immunotherapy, 1, regulatory T cell, 2, Immune checkpoint, 3, Cytokine receptors, 4, Tumor immunology, 5
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 104, Issue -, Pages 108469
Publisher
Elsevier BV
Online
2022-01-08
DOI
10.1016/j.intimp.2021.108469
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer
- (2021) Ryoichi Katsube et al. Scientific Reports
- Addition of anti-TIM3 or anti-TIGIT Antibodies to anti-PD1 Blockade Augments Human T cell Adoptive Cell Transfer
- (2021) Marina Martinez et al. OncoImmunology
- The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3
- (2021) Elly Marcq et al. Cancers
- Fluorescence Imaging of Tumor-Accumulating Antibody-IR700 Conjugates Prior to Near-Infrared Photoimmunotherapy (NIR-PIT) Using a Commercially Available Camera Designed for Indocyanine Green
- (2021) Fuyuki F. Inagaki et al. MOLECULAR PHARMACEUTICS
- Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells
- (2021) Rebekka Duhen et al. Nature Communications
- Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy
- (2021) Helena Van Damme et al. Journal for ImmunoTherapy of Cancer
- Fc-optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models
- (2021) Joseph R Campbell et al. CANCER RESEARCH
- CCR4 in cutaneous T‐cell lymphoma: Therapeutic targeting of a pathogenic driver
- (2021) Jan P. Nicolay et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function
- (2021) Sarah K. Whiteside et al. IMMUNOLOGY
- Triple-modality therapy maximizes antitumor immune responses in a mouse model of mesothelioma
- (2021) Junichi Murakami et al. Science Translational Medicine
- Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
- (2021) Zohreh Amoozgar et al. Nature Communications
- Urelumab alone or in combination with rituximab in patients with relapsed or refractory B‐cell lymphoma
- (2020) John Timmerman et al. AMERICAN JOURNAL OF HEMATOLOGY
- Tumor necrosis factor receptor family co‐stimulation increases regulatory T cell activation and function via NF‐κB
- (2020) Martina Lubrano di Ricco et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target
- (2020) Zachary T. Freeman et al. JOURNAL OF CLINICAL INVESTIGATION
- CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer
- (2020) Tao Wang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapy
- (2020) Laura A. Vitale et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IL36 Cooperates With Anti-CTLA-4 mAbs to Facilitate Antitumor Immune Responses
- (2020) Qiuxia Qu et al. Frontiers in Immunology
- Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as a Single Agent and in Combination with Checkpoint Inhibitors
- (2020) Omar Robles et al. JOURNAL OF MEDICINAL CHEMISTRY
- Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies
- (2020) Stephen M. Ansell et al. Blood Advances
- Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors
- (2020) Bonnie S. Glisson et al. CLINICAL CANCER RESEARCH
- A Cross-Species Reactive TIGIT-Blocking Antibody Fc Dependently Confers Potent Antitumor Effects
- (2020) Fang Yang et al. JOURNAL OF IMMUNOLOGY
- ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models
- (2020) Amanda Hanson et al. PLoS One
- New emerging targets in cancer immunotherapy: the role of GITR
- (2020) Giulia Buzzatti et al. ESMO Open
- α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas
- (2019) E. Dodagatta-Marri et al. Journal for ImmunoTherapy of Cancer
- Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma
- (2019) Thomas A Ollila et al. OncoTargets and Therapy
- Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti–PD-1 in melanoma
- (2019) Laurene S. Cheung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GITR ligation enhances functionality of tumor‐infiltrating T cells in hepatocellular carcinoma
- (2019) Adriaan A. Beek et al. INTERNATIONAL JOURNAL OF CANCER
- Zoledronic acid blocks the interaction between breast cancer cells and regulatory T-cells
- (2019) Hsien Liu et al. BMC CANCER
- Rational design of anti-GITR-based combination immunotherapy
- (2019) Roberta Zappasodi et al. NATURE MEDICINE
- PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
- (2019) Takahiro Kamada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation
- (2019) Anne Månsson Kvarnhammar et al. Journal for ImmunoTherapy of Cancer
- Cancer neovasculature-targeted near-infrared photoimmunotherapy (NIR-PIT) for gastric cancer: different mechanisms of phototoxicity compared to cell membrane-targeted NIR-PIT
- (2019) Takashi Nishimura et al. Gastric Cancer
- Discovery of a Potent and Selective CCR4 Antagonist That Inhibits Treg Trafficking into the Tumor Microenvironment
- (2019) Jeffrey J. Jackson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4+CD25+Foxp3+ and CD4+CD25−Foxp3+ T cells
- (2019) Magdalena J. Polanczyk et al. Journal of Translational Medicine
- Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1
- (2019) Marine Leclerc et al. Nature Communications
- The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near-Infrared Photoimmunotherapy
- (2019) Ryuhei Okada et al. BIOCONJUGATE CHEMISTRY
- A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors
- (2019) Toshihiko Doi et al. CLINICAL CANCER RESEARCH
- Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma
- (2019) Lei Wu et al. Cancer Immunology Research
- Therapeutic strategies for the costimulatory molecule OX40 in T-cell mediated immunity
- (2019) Yu Fu et al. Acta Pharmaceutica Sinica B
- The Role Of PD-1/PD-L1 Axis In Treg Development And Function: Implications For Cancer Immunotherapy
- (2019) Jiajing Cai et al. OncoTargets and Therapy
- Pembrolizumab Interferes with the Differentiation of Human FOXP3+–Induced T Regulatory Cells, but Not with FOXP3 Stability, through Activation of mTOR
- (2019) Varun Sasidharan Nair et al. JOURNAL OF IMMUNOLOGY
- Depleting tumor-associated Tregs via nanoparticle-mediated hyperthermia to enhance anti-CTLA-4 immunotherapy
- (2019) Hongwei Chen et al. Nanomedicine
- Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy
- (2019) Yang Liu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Targeting CCR8 induces protective antitumor immunity and enhances vaccine-induced responses in colon cancer
- (2018) Daniel O Villarreal et al. CANCER RESEARCH
- A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
- (2018) Xuexiang Du et al. CELL RESEARCH
- Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer
- (2018) Neil H. Segal et al. CLINICAL CANCER RESEARCH
- Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer
- (2018) Jian-Feng Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Immunoregulatory functions and the therapeutic implications of GARP-TGF-β in inflammation and cancer
- (2018) Alessandra Metelli et al. Journal of Hematology & Oncology
- Combination immune checkpoint blockade as an effective therapy for mesothelioma
- (2018) Vanessa S. Fear et al. OncoImmunology
- MiR-21 Participates in the PD-1/PD-L1 Pathway-Mediated Imbalance of Th17/Treg Cells in Patients After Gastric Cancer Resection
- (2018) Xiaoyu Zheng et al. ANNALS OF SURGICAL ONCOLOGY
- Increased Expression of GARP in Papillary Thyroid Carcinoma
- (2018) Xiaoxu Zhang et al. ENDOCRINE PATHOLOGY
- Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function
- (2018) Sarah L. Buchan et al. IMMUNITY
- Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression
- (2018) Elena Gianchecchi et al. Frontiers in Immunology
- Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
- (2017) Frederick Arce Vargas et al. IMMUNITY
- Tim-3 and its role in regulating anti-tumor immunity
- (2017) Madhumita Das et al. IMMUNOLOGICAL REVIEWS
- Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-β signaling
- (2017) Ephraim A. Ansa-Addo et al. JOURNAL OF CLINICAL INVESTIGATION
- CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy
- (2017) Anna Wasiuk et al. JOURNAL OF IMMUNOLOGY
- Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti–CD44-Based NIR-PIT
- (2017) Tadanobu Nagaya et al. MOLECULAR CANCER RESEARCH
- OX40: Structure and function – What questions remain?
- (2017) Jane Willoughby et al. MOLECULAR IMMUNOLOGY
- A TIM-3 Oligonucleotide Aptamer Enhances T Cell Functions and Potentiates Tumor Immunity in Mice
- (2017) Tal Gefen et al. MOLECULAR THERAPY
- Combined OX40L and mTOR blockade controls effector T cell activation while preserving T reg reconstitution after transplant
- (2017) Victor Tkachev et al. Science Translational Medicine
- Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
- (2017) Dmitriy Zamarin et al. Nature Communications
- A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice
- (2017) Jeremy B. Foote et al. Cancer Immunology Research
- Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer
- (2017) Dhifaf Sarhan et al. OncoImmunology
- Immune modulation of CD4+CD25+ regulatory T cells by zoledronic acid
- (2016) Hsien Liu et al. BMC IMMUNOLOGY
- Dual Roles for Regulatory T-cell Depletion and Costimulatory Signaling in Agonistic GITR Targeting for Tumor Immunotherapy
- (2016) Ashley E. Mahne et al. CANCER RESEARCH
- Surface Expression of TGFβ Docking Receptor GARP Promotes Oncogenesis and Immune Tolerance in Breast Cancer
- (2016) Alessandra Metelli et al. CANCER RESEARCH
- Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
- (2016) Neil H. Segal et al. CLINICAL CANCER RESEARCH
- Rationale for anti-GITR cancer immunotherapy
- (2016) Deborah A. Knee et al. EUROPEAN JOURNAL OF CANCER
- Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer
- (2016) George Plitas et al. IMMUNITY
- Methionine enkephalin, its role in immunoregulation and cancer therapy
- (2016) Dingliang Zhao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Near infrared photoimmunotherapy of B-cell lymphoma
- (2016) Tadanobu Nagaya et al. Molecular Oncology
- Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
- (2016) Celine Boutros et al. Nature Reviews Clinical Oncology
- Effects of active bufadienolide compounds on human cancer cells and CD4+CD25+Foxp3+ regulatory T cells in mitogen-activated human peripheral blood mononuclear cells
- (2016) Bo Yuan et al. ONCOLOGY REPORTS
- Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival
- (2016) Jian-Fei Tu et al. Scientific Reports
- Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma
- (2015) M. Duvic et al. BLOOD
- Methionine Enkephalin (MENK) Inhibits tumor growth through regulating CD4+Foxp3+ Regulatory T cells (Tregs) in mice
- (2015) Xuan Li et al. CANCER BIOLOGY & THERAPY
- Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients--Report of a Phase I/IIa Clinical Trial
- (2015) A. Legat et al. CLINICAL CANCER RESEARCH
- Cancer Immunotherapy: A Future Paradigm Shift in the Treatment of Non-Small Cell Lung Cancer
- (2015) V. K. Anagnostou et al. CLINICAL CANCER RESEARCH
- Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3highregulatory T cells in humans
- (2015) Makoto Miyara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients
- (2015) Emanuela Romano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulatory T Cells Inhibit Dendritic Cells by Lymphocyte Activation Gene-3 Engagement of MHC Class II
- (2014) Bitao Liang et al. JOURNAL OF IMMUNOLOGY
- Methionine enkephalin (MENK) improves lymphocyte subpopulations in human peripheral blood of 50 cancer patients by inhibiting regulatory T cells (Tregs)
- (2014) Qiushi Wang et al. Human Vaccines & Immunotherapeutics
- Genome-wide DNA methylation analysis identifies hypomethylated genes regulated by FOXP3 in human regulatory T cells
- (2013) Y. Zhang et al. BLOOD
- Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
- (2013) J. Duraiswamy et al. CANCER RESEARCH
- Modulation of Treg cells/T effector function by GITR signaling is context-dependent
- (2013) Amal Ephrem et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
- (2013) Aurélien Marabelle et al. JOURNAL OF CLINICAL INVESTIGATION
- TGF- : Guardian of T Cell Function
- (2013) S. A. Oh et al. JOURNAL OF IMMUNOLOGY
- Agonist Anti-Human CD27 Monoclonal Antibody Induces T Cell Activation and Tumor Immunity in Human CD27-Transgenic Mice
- (2013) L.-Z. He et al. JOURNAL OF IMMUNOLOGY
- MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways
- (2013) X Li et al. ONCOGENE
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- Combined Targeting of Costimulatory (OX40) and Coinhibitory (CTLA-4) Pathways Elicits Potent Effector T Cells Capable of Driving Robust Antitumor Immunity
- (2013) W. L. Redmond et al. Cancer Immunology Research
- CD4+CD25+CD127low/− T Cells: A More Specific Treg Population in Human Peripheral Blood
- (2012) Ning Yu et al. INFLAMMATION
- Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment
- (2012) Moshe Rogosnitzky et al. INVESTIGATIONAL NEW DRUGS
- Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphoma
- (2011) S M Ansell et al. LEUKEMIA
- Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients
- (2010) J. F. M. Jacobs et al. CLINICAL CANCER RESEARCH
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
- (2010) Chrystelle Brignone et al. Journal of Translational Medicine
- A Phase I Pharmacokinetic and Biological Correlative Study of IMP321, a Novel MHC Class II Agonist, in Patients with Advanced Renal Cell Carcinoma
- (2009) C. Brignone et al. CLINICAL CANCER RESEARCH
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
- (2009) Loise M. Francisco et al. JOURNAL OF EXPERIMENTAL MEDICINE
- GARP (LRRC32) is essential for the surface expression of latent TGF- on platelets and activated FOXP3+ regulatory T cells
- (2009) D. Q. Tran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now